Secondhand smoke risk in infants discharged from an NICU: potential for significant health disparities?

Angela L Stotts1, Patricia W Evans, Charles E Green

  • 1Family and Community Medicine, University of Texas Medical School at Houston, 6431 Fannin, JJL 324, Houston, TX 77030, USA. angela.l.stotts@uth.tmc.edu

Insights

Disadvantaged families with high-risk infants are less likely to implement smoking bans, increasing secondhand smoke exposure risks. Targeted interventions are crucial for these vulnerable populations to reduce health disparities.

Area of Science:

  • Neonatal care
  • Public health
  • Environmental health

Background:

  • Secondhand smoke exposure (SHSe) poses significant risks to infants discharged from neonatal intensive care units (NICUs).
  • This study investigated smoking practices in families with high-risk infants, focusing on socioeconomic factors, race, and mental health.
  • Understanding these factors is crucial for developing effective interventions.

Purpose of the Study:

  • To examine the relationship between sociodemographic factors and the implementation of household smoking bans.
  • To identify disparities in secondhand smoke exposure among infants at high risk.
  • To inform the development of targeted interventions for vulnerable families.

Main Methods:

  • Data were collected from 99 families participating in The Baby's Breath Project, a hospital-based SHSe intervention trial.
  • Participants included parents of high-risk infants in the NICU with a household smoker.
  • Measures included sociodemographics, smoking habits, home and car smoking bans, and maternal depression.

Main Results:

  • 26% of families with high-risk infants reported a household smoker, with nearly half earning less than $25,000 annually.
  • Only 27.8% of low-income families had a total smoking ban, compared to nearly 60% of higher-income families (p < .01).
  • African American and Caucasian families were less likely to have bans than Hispanic families (p < .05), and mothers without bans reported higher depression scores (p < .02).

Conclusions:

  • Disadvantaged families exhibit lower adoption of protective behaviors against SHSe, increasing infant risk.
  • These disparities contribute to tobacco-related health inequities in vulnerable populations.
  • Innovative SHSe interventions are urgently needed for families with high-risk infants.
Abstract

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...